These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 22593482)
1. Expression of podoplanin in primary and metastatic poorly differentiated and undifferentiated carcinomas of the head and neck. Friedrich RE; Bartel-Friedrich S; Hagel C Anticancer Res; 2012 May; 32(5):2019-22. PubMed ID: 22593482 [TBL] [Abstract][Full Text] [Related]
2. Podoplanin expression in cutaneous head and neck squamous cell carcinoma--prognostic value and clinicopathologic implications. Kreppel M; Krakowezki A; Kreppel B; Drebber U; Wedemeyer I; Mauch C; Zöller JE; Scheer M J Surg Oncol; 2013 Mar; 107(4):376-83. PubMed ID: 22886751 [TBL] [Abstract][Full Text] [Related]
3. Understanding patterns of invasion: a novel approach to assessment of podoplanin expression in the prediction of lymph node metastasis in oral squamous cell carcinoma. Sharma A; Boaz K; Natarajan S Histopathology; 2018 Mar; 72(4):672-678. PubMed ID: 29023936 [TBL] [Abstract][Full Text] [Related]
4. Expression of DOG1 (Using SP31) in Poorly Differentiated Carcinoma of the Head and Neck. Friedrich RE; Wunder T; Schumacher U; Bartel-Friedrich S; Zustin J Anticancer Res; 2016 Jun; 36(6):3117-22. PubMed ID: 27272836 [TBL] [Abstract][Full Text] [Related]
5. Characterisation of Prognosis and Invasion of Cutaneous Squamous Cell Carcinoma by Podoplanin and E-Cadherin Expression. Hesse K; Satzger I; Schacht V; Köther B; Hillen U; Klode J; Schaper K; Gutzmer R Dermatology; 2016; 232(5):558-565. PubMed ID: 27875814 [TBL] [Abstract][Full Text] [Related]
6. Podoplanin expression in lymph node metastases of head and neck cancer and cancer of unknown primary patients. Kühn JP; Bochen F; Körner S; Schick B; Wagner M; Smola S; Berkó-Göttel B; Morris LGT; Wang J; Bozzato A; Linxweiler M Int J Biol Markers; 2022 Sep; 37(3):280-288. PubMed ID: 35880270 [TBL] [Abstract][Full Text] [Related]
7. Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival. de Vicente JC; Santamarta TR; Rodrigo JP; García-Pedrero JM; Allonca E; Blanco-Lorenzo V Virchows Arch; 2015 May; 466(5):549-58. PubMed ID: 25726183 [TBL] [Abstract][Full Text] [Related]
8. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. Huber GF; Fritzsche FR; Züllig L; Storz M; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H Int J Cancer; 2011 Sep; 129(6):1404-9. PubMed ID: 21105028 [TBL] [Abstract][Full Text] [Related]
9. Induction of epithelial-mesenchymal transition and loss of podoplanin expression are associated with progression of lymph node metastases in human papillomavirus-related oropharyngeal carcinoma. Wakisaka N; Yoshida S; Kondo S; Kita M; Sawada-Kitamura S; Endo K; Tsuji A; Nakanish Y; Murono S; Yoshizaki T Histopathology; 2015 May; 66(6):771-80. PubMed ID: 25039283 [TBL] [Abstract][Full Text] [Related]
10. Podoplanin expression and its emerging role as a prognostic indicator in systemic tumors besides head and neck malignancies. Kapoor S J Surg Oncol; 2013 Mar; 107(4):446. PubMed ID: 22991299 [No Abstract] [Full Text] [Related]
11. Podoplanin is involved in the prognosis of head and neck squamous cell carcinoma through interaction with VEGF-C. Kim HY; Rha KS; Shim GA; Kim JH; Kim JM; Huang SM; Koo BS Oncol Rep; 2015 Aug; 34(2):833-42. PubMed ID: 26081937 [TBL] [Abstract][Full Text] [Related]
12. Podoplanin Expression Is Correlated With the Progression of Chronic Discoid Lupus Erythematosus to Lip Squamous Cell Carcinoma. Gao X; Ma L; Zhou Z; Jian X; Liu W Int J Surg Pathol; 2016 Oct; 24(7):595-9. PubMed ID: 27240861 [TBL] [Abstract][Full Text] [Related]
13. Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy. Vormittag L; Thurnher D; Geleff S; Pammer J; Heiduschka G; Brunner M; Grasl MCh; Erovic BM Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):913-8. PubMed ID: 19215825 [TBL] [Abstract][Full Text] [Related]
14. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma. Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509 [TBL] [Abstract][Full Text] [Related]
15. Immunolocalization of E-cadherin in human head and neck cancer. Sorscher SM; Russack V; Cagle M; Feramisco JR; Green MR Arch Pathol Lab Med; 1995 Jan; 119(1):82-4. PubMed ID: 7802560 [TBL] [Abstract][Full Text] [Related]
16. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. Plaza JA; Ortega PF; Stockman DL; Suster S J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670 [TBL] [Abstract][Full Text] [Related]
17. Investigation of biomarker in laryngeal carcinomas. Kanliada D; Coskunpinar E; Orhan KS; Oltulu YM; Celik M; Eren A; Yaylim I; Deger K J Clin Lab Anal; 2014 May; 28(3):186-90. PubMed ID: 24395286 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of CD44v6, p63, podoplanin and MMP-9 in oral squamous cell carcinomas. Monteiro LS; Delgado ML; Ricardo S; do Amaral B; Salazar F; Pacheco JJ; Lopes CA; Bousbaa H; Warnakulasuryia S Oral Dis; 2016 May; 22(4):303-12. PubMed ID: 26788715 [TBL] [Abstract][Full Text] [Related]
19. Role of podoplanin expression in squamous cell carcinoma of upper aerodigestive tract. Chuang WY; Chang YS; Yeh CJ; Wu YC; Hsueh C Histol Histopathol; 2013 Mar; 28(3):293-9. PubMed ID: 23348382 [TBL] [Abstract][Full Text] [Related]
20. Role of podoplanin in potentially malignant disorders and oral squamous cell carcinoma and its correlation with lymphangiogenesis. Parhar S; Kaur H; Vashist A; Verma S Indian J Cancer; 2015; 52(4):617-22. PubMed ID: 26960495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]